National Institutes of Health
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing June 16, 2028.
Overview
Opportunity Listing - Exploratory Clinical Neuroscience Research on Substance Use DisordersSkip to main contentAn official website of the United States governmentHere’s how you knowHere’s how you knowOfficial websites use .govA .gov website belongs to an official government organization in the United States.Secure…